Immune dysregulation in fibromyalgia: Targeting the NLRP3 inflammasome-ferroptosis axis as a novel therapeutic strategy for chronic pain

Clinical Immunology · Published 2026-04-08 · DOI 10.1016/j.clim.2026.110704

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.clim.2026.110704

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles